Europe Cardiac Rhythm Management Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Europe Cardiac Rhythm Management Devices Market is segmented by Product (Defibrillators, Pacemakers, and Cardiac Resynchronization Therapy Devices) and Geography

Market Snapshot

cardiac rhythm management devices market
Study Period: 2018 - 2026
Base Year: 2020
CAGR: 4.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Europe Cardiac Rhythm Management Devices Market is expected to register a CAGR of 4.5% during the forecast period. The market has shown consistent growth owing to the increasing prevalence of cardiovascular disorders, technological advancements, and rise in the use of ambulatory and home services for cardiac monitoring.

The increasing prevalence of cardiovascular disorders is one of the major factors driving the cardiac rhythm management devices market. According to the European Cardiovascular Disease Statistics 2017, each year cardiovascular disease (CVD) causes approximately 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU). Therefore CVDs occur almost equally in men and women.

With the rise in the aging population in Europe, a number of patients suffering from heart rhythm disorders are likely to witness an increase and this is a cause of concern. There are also technological innovations in product delivery which is anticipated to witness strong growth with product innovation.

Scope of the Report

As per the scope of the report, cardiac rhythm management is a part of electrophysiology, which is used to manage the functioning of the heart. The last decade has observed an ongoing evolution and the use of cardiac rhythm management devices, including cardiac resynchronization therapy, pacemakers, implantable cardioverter defibrillators, and loop recorders. General practitioners (GP) are increasingly involved in the follow-up and management of patients with these devices.

By Product
Defibrillators
Implantable Cardioverter Defibrillators (ICDS)
External Defibrillators (ED)
Pacemakers
Implantable Pacemakers (ICPS)
External Pacemakers
Cardiac Resynchronization Therapy Devices
Cardiac Resynchronization Therapy Defibrillators (CRT-D)
Cardiac Resynchronization Therapy Pacemakers (CRT-P)
Geography
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe

Report scope can be customized per your requirements. Click here.

Key Market Trends

Defibrillator Segment is Expected to Hold a Major Share During the Forecast Period

Defibrillator is a medical device that restores a normal heartbeat by sending an electric pulse or shock to the heart. This device is used to treat cardiac conditions such as arrhythmia, a heartbeat that is uneven or that is too slow or too fast. The use of a defibrillator is increasing due to its efficacy in treating cardiac arrest.

According to the European Cardiovascular Disease Statistics 2017, cardiovascular disease (CVD) accounts for 45% of all deaths in Europe and 37% of all deaths in the European Union (EU). Moreover, death rates from both ischaemic heart disease (IHD) and stroke are generally higher in Central and Eastern Europe than in Northern, Southern, and Western Europe. Furthermore, there is also an expansion in the market for external defibrillators as governments in developed economies have been working on making countries more cardio-friendly, which improves the usage of defibrillators across single and multispeciality hospitals.

Europe key trend 1.png

Competitive Landscape

The European cardiac rhythm management devices market is highly competitive and consists of a few major players. Companies like Abbott, Abiomed, Biotronik SE & Co KG, Boston Scientific Corporation, Koninklijke Philips NV, LivaNova Plc, Medtronic PLC, SchillerAG, Shenzhen Mindray Biomedical Electronics Co. Ltd, among others, hold the substantial market share in the cardiac rhythm management devices market. Geographical expansion, collaboration, mergers and acquisitions, and new product development are some of the key undertakings of players in the cardiac rhythm management devices market.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Cardiovascular Disorders

      2. 4.2.2 Technological Advancements

      3. 4.2.3 Rise in the Use of Ambulatory and Home Services for Cardiac Monitoring

    3. 4.3 Market Restraints

      1. 4.3.1 Effects of Therapeutic Radiation on Implantable Cardiac Rhythm Devices

      2. 4.3.2 High Cost of Devices

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Defibrillators

        1. 5.1.1.1 Implantable Cardioverter Defibrillators (ICDS)

        2. 5.1.1.2 External Defibrillators (ED)

      2. 5.1.2 Pacemakers

        1. 5.1.2.1 Implantable Pacemakers (ICPS)

        2. 5.1.2.2 External Pacemakers

      3. 5.1.3 Cardiac Resynchronization Therapy Devices

        1. 5.1.3.1 Cardiac Resynchronization Therapy Defibrillators (CRT-D)

        2. 5.1.3.2 Cardiac Resynchronization Therapy Pacemakers (CRT-P)

    2. 5.2 Geography

      1. 5.2.1 Europe

        1. 5.2.1.1 Germany

        2. 5.2.1.2 United Kingdom

        3. 5.2.1.3 France

        4. 5.2.1.4 Italy

        5. 5.2.1.5 Spain

        6. 5.2.1.6 Rest of Europe

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Biotronik SE & Co KG

      3. 6.1.3 Boston Scientific Corporation

      4. 6.1.4 Koninklijke Philips NV

      5. 6.1.5 LivaNova Plc

      6. 6.1.6 Medtronic PLC

      7. 6.1.7 SchillerAG

      8. 6.1.8 Shenzhen Mindray Biomedical Electronics Co., Ltd

      9. 6.1.9 Zoll Medical Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Europe Cardiac Rhythm Management Devices Market market is studied from 2018 - 2026.

The Europe Cardiac Rhythm Management Devices Market is growing at a CAGR of 4.5% over the next 5 years.

Abbott Laboratories, Medtronic PLC, Biotronik SE & Co KG, Boston Scientific Corporation, Koninklijke Philips NV are the major companies operating in Europe Cardiac Rhythm Management Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!